News
6don MSN
By Julie Steenhuysen CHICAGO (Reuters) -Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at ...
Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...
A clinical trial found that women could switch drugs without waiting for scans showing cancer progression, which improved ...
AstraZeneca targets $80bn revenue by 2030, driven by oncology and new drugs, but faces patent risks and tough competition.
Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, ...
AstraZeneca, a major pharmaceutical company, has sued Utah’s Attorney General Derek Brown over a recently passed state law ...
5d
Investor's Business Daily on MSNHow AstraZeneca Is Playing Its Cancer Cards To Become An $80 Billion PharmaThree new cancer drugs could help AstraZeneca make a dent in its lofty ambition to become an $80 billion company by 2030.
23h
ABC4 Utah on MSNPharmaceutical company AstraZeneca sues Utah Attorney General over discount medication lawThe pharmaceutical company AstraZeneca has filed a federal lawsuit against Utah Attorney General Derek Brown and Utah ...
The pharmaceutical drug company AstraZeneca filed a lawsuit against the Utah attorney general claiming Utah's new law on limiting prescription drug prices goes against a federal program.
Drugmaker AstraZeneca has agreed to pay $50.9 million to settle a class action lawsuit in U.S. court accusing the company of ...
Pharmaceutical giant AstraZeneca is suing Utah’s attorney general and insurance commissioner over a law passed during the ...
AstraZeneca continues to impress me with the strong performances of its oncology, cardiovascular, and rare disease franchises ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results